Get Your 7-Day Free Trial! Start Now!
Get Premium to unlock powerful stock data
NYSE:BHC (Canada)  
Manual of Stocks™
Bausch Health Companies Inc logo

Bausch Health Companies Inc

$ 8.53 +0.17 (+2.03%) 08:08 PM EST
Warning! GuruFocus has detected 4 Severe warning signs with BHC. Subscribe to check it out.
P/E:
At Loss
P/B:
0
Market Cap:
$ 3.02B
Enterprise V:
$ 24.94B
Volume:
3.43M
Avg Vol (2M):
8.60M
Also Trade In:
Volume:
3.43M
Market Cap $:
3.02B
PE Ratio:
At Loss
Avg Vol (2-Month):
8.60M
Enterprise Value $:
24.94B
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Bausch Health Companies Inc
NAICS : 325412 SIC : 3741
https://www.bauschhealth.com
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Compare
Compare
XCNQ:CURA • XCNQ:TRUL • XCNQ:VRNO • XCNQ:GTII • TSX:WEED • TSX:CRON • XCNQ:CL • XCNQ:TER • NEOE:CCHW • TSX:GUD • NYSE:ZTS • XTER:MRK • TSE:4502 • NSE:SUNPHARMA • NYSE:CTLT • SZSE:000538 • SHSE:600196 • TSE:4507 • NAS:VTRS • SZSE:000661
Traded in other countries / regions
BHC.Canada • BVF.Germany • BHC.Mexico • VRX.Switzerland • 0QYW.UK • BHC.USA
Description
Formerly known as Valeant Pharmaceuticals, Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Bausch+Lomb (45% of revenue), Salix Pharmaceuticals (24%), international pharma (14%), ortho dermatology (7%), and diversified products (10%). Bausch is the market leader in consumer visioncare in India and China and the fourth-largest visioncare company by sales in the United States.

Financial Strength

3/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset -0.01
Debt-to-Equity -107.26
Debt-to-EBITDA 9.61
Interest Coverage 0.69
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.06
Distress
Grey
Safe
Beneish M-Score -2.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

2/10
Name Current Vs Industry Vs History
5-Day RSI 59.81
9-Day RSI 51.42
14-Day RSI 42.46
6-1 Month Momentum % -65.34
12-1 Month Momentum % -68.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.22
Quick Ratio 1
Cash Ratio 0.26
Days Inventory 161.8
Days Sales Outstanding 71.72
Days Payable 65.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.9

Financials (Next Earnings Date:2022-08-03 Est.)

BHC's 30-Y Financials

Guru Trades

See Details
To
EMBED
 SAVE

Insider Trades

See Details
To
EMBED
 SAVE

Gurus Latest Trades with NYSE:BHC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
 SAVE
Dividend
To
EMBED
 SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

GF Value: $24.03
BHC
EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8,325
EPS (TTM) ($) -1.14
Beta 1.55
Volatility % 53.87
14-Day RSI 42.46
14-Day ATR ($) 0.61786
20-Day SMA ($) 8.1745
12-1 Month Momentum % -68.16
52-Week Range ($) 6.88 - 30.3
Shares Outstanding (Mil) 361.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bausch Health Companies Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More
Get Premium to unlock powerful stock data
Product
Home
Site Map
Mobile App
Email Alerts
中文
Business
Advertise
Referral Program
Affiliate Program
Information
Career
RSS
FAQ
Contact Us
About
About Us
ADV Part 2A
ADV Part 2B
ADV Part 3
Term of Use
Privacy Policy
Affiliate Program
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.
© 2004-2022 GuruFocus.com, LLC. All Rights Reserved.